Jung Bok Lee

Jung Bok Lee

Auto-generated profile, based on publicly available information

Jung Bok Lee

Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YYYoo-Seok Yoon
Yoo-Seok Yoon
WLWoohyung Lee
Woohyung Lee
CKChang Moo Kang
Chang Moo Kang
THTaeho Hong
Taeho Hong
Sang Hyun ShinSang Hyun Shin
Sang Hyun Shin
Song Cheol KimSong Cheol Kim
Song Cheol Kim
Background: There is a lack of robust evidence on the efficacy of laparoscopic pancreatoduodenectomy compared to open surgery. This study was aimed to compare time to functional recovery (FR) between laparoscopic and open pancreatoduodenectomy. Materials and methods: This pragmatic, multicenter, randomized controlled phase 3 trial was conducted in seven tertiary centers. Patients with periampullary tumors were randomized using a block design in a 1:1 ratio and stratified by pancreatic fistula risk. Participants were randomized to undergo open or laparoscopic pancreatoduodenectomy by expert pancreatic surgeons. The primary outcome was the time to FR, defined as the number of days until FR was achieved in all five domains. The secondary endpoints included perioperative and short-term oncological outcomes. Results: Between March 2019 and June 2022, 252 patients were randomly assigned to laparoscopic (n=125) or open groups (n=127). Primary outcomes were reported in 235 patients. The mean time to FR was shorter in laparoscopic group compared to the open group (7.7 vs. 9.0 days, P=0.03). Laparoscopic group exhibited a higher cumulative rate of FR compared to the open group (Hazard ratio,1.34; 95% CI, 1.03–1.74; P=0.02). Severe complications, R0 resection, the number of retrieved lymph nodes and short-term survival rates were comparable between the two groups. Conclusions: Laparoscopic pancreatoduodenectomy demonstrated modest advantages in FR time over open surgery for selected patients with experienced surgeons.

18 December 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
YPYe-Eun Park
Ye-Eun Park
YTYae Won Tak
Yae Won Tak
IKInhye Kim
Inhye Kim
HLHui Jeong Lee
Hui Jeong Lee
JLJung Bok Lee
Jung Bok Lee
YLYura Lee
Yura Lee
Background: The shift in medical care toward prediction and prevention has led to the emergence of digital health care as a valuable tool for managing health issues. Aiding long-term follow-up care for cancer survivors and contributing to improved survival rates. However, potential barriers to mobile health usage, including age-related disparities and challenges in user retention for commercial health apps, highlight the need to assess the impact of patients’ abilities and health status on the adoption of these interventions. Objective: This study aims to investigate the app adherence and user experience of commercial health care apps among cancer survivors using an extended technology acceptance model (TAM). Methods: The study enrolled 264 cancer survivors. We collected survey results from May to August 2022 and app usage records from the app companies. The survey questions were created based on the TAM. Results: We categorized 264 participants into 3 clusters based on their app usage behavior: short use (n=77), medium use (n=101), and long use (n=86). The mean usage days were 9 (SD 11) days, 58 (SD 20) days, and 84 (SD 176) days, respectively. Analysis revealed significant differences in perceived usefulness (P=.01), interface satisfaction (P<.01), equity (P<.01), and utility (P=.01) among the clusters. Structural equation modeling indicated that perceived ease-of-use significantly influenced perceived usefulness (β=0.387, P<.01), and both perceived usefulness and attitude significantly affected behavioral intention and actual usage. Conclusions: This study showed the importance of positive user experience and clinician recommendations in facilitating the effective usage of digital health care tools among cancer survivors and contributing to the evolving landscape of medical care.

26 April 2022 in Radiology
Verified
Journal Article
Closed access
SHSu Min Ha
Su Min Ha
ACA Jung Chu
A Jung Chu
JLJungBok Lee
JungBok Lee
SKSoo-Yeon Kim
Soo-Yeon Kim
SLSu Hyun Lee
Su Hyun Lee
JCJung Min Chang
Jung Min Chang
COVID-19 vaccine–associated lymphadenopathy should be interpreted considering the vaccine type and interval from vaccination; follow-up US examination at least 12 weeks after vaccination may be rea... Background Both temporal changes in imaging characteristics of lymphadenopathy on US scans after COVID-19 vaccination and expected duration of radiologically evident lymphadenopathy remain uncertai...

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
DKDong Wook Kim
Dong Wook Kim
KKKyung Won Kim
Kyung Won Kim
YKYousun Ko
Yousun Ko
TPTaeyong Park
Taeyong Park
JLJeongjin Lee
Jeongjin Lee
HKHong-Kyu Kim
Hong-Kyu Kim
Kim DW, et al. Korean J Radiol. 2021 Nov;22(11):1909-1917. https://doi.org/10.3348/kjr.2021.0105

22 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
JKJwa Hoon Kim
Jwa Hoon Kim
CYChanghoon Yoo
Changhoon Yoo
SSSeyoung Seo
Seyoung Seo
JJJae Ho Jeong
Jae Ho Jeong
BRBaek-Yeol Ryoo
Baek-Yeol Ryoo
SPSook Ryun Park
Sook Ryun Park
Background: We evaluated the safety and efficacy of direct oral anticoagulants (DOACs) versus subcutaneous dalteparin for cancer-associated venous thromboembolism (CA-VTE) in patients with advanced upper gastrointestinal (GI) tract, hepatobiliary, or pancreatic cancer. Methods: This was a multicenter, randomized, open-label, phase II trial in five centers. Patients randomly received rivaroxaban (15 mg twice daily for 3 weeks, then 20 mg once daily)/apixaban (10 mg twice daily for the first 7 days, then 5 mg twice daily) or dalteparin (200 IU/kg once daily for the first month, then 150 IU/kg once daily). Randomization was stratified by the Eastern Cooperative Oncology Group Performance Status, primary cancer type, active chemotherapy, and participating centers. The primary endpoint was the rates of clinically relevant bleeding (CRB) in the full analysis set (FAS). Results: A total of 90 patients were randomly assigned to the DOAC (n = 44) and dalteparin groups (n = 46) in FAS. CRB and major bleeding (MB) rates were 34.1% and 13.0% (p = 0.018) and 18.2% and 4.3% (p = 0.047) for the DOAC and dalteparin groups, respectively. Time to CRB and MB was higher in the DOAC group than in the dalteparin group (hazard ratio [HR] 2.83; p = 0.031 and HR 4.32; p = 0.064). Cancer involvement at the GI mucosa was also a significant risk factor for CRB. Recurrent CA-VTE occurred in 2.3% and 2.2% of patients given DOAC and dalteparin, respectively (p = 1.000). Conclusion: DOAC therapy further increased the risk of bleeding compared with dalteparin in patients with active advanced upper GI tract, hepatobiliary, or pancreatic cancer, suggesting that extra caution should be taken when selecting anticoagulants for CA-VTE.

27 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJi-Yeon Bang
Ji-Yeon Bang
IJIn-Gu Jun
In-Gu Jun
JLJeong-Bok Lee
Jeong-Bok Lee
YKYousun Ko
Yousun Ko
KKKyung Won Kim
Kyung Won Kim
JSJun-Gol Song
Jun-Gol Song
Background: Sarcopenia contributes to increased morbidity and mortality in patients undergoing surgery for abdominal aortic aneurysms (AAA). However, few reports have demonstrated whether sarcopenia would affect the development of postoperative acute kidney injury (AKI) in these patients. This study aimed to examine whether sarcopenia is associated with AKI and morbidity and mortality after infrarenal AAA operation. Methods: We retrospectively analysed 379 patients who underwent infrarenal AAA surgery. The diagnosis of sarcopenia was performed using the skeletal muscle index, which was calculated from axial computed tomography at the level of L3. The patients were separated into those with sarcopenia (n = 104) and those without sarcopenia (n = 275). We applied multivariable and Cox regression analyses to evaluate the risk factors for AKI and overall mortality. A propensity score matching (PSM) evaluation was done to assess the postoperative results. Results: The incidence of AKI was greater in sarcopenia than non-sarcopenia group before (34.6% vs. 15.3%; p < 0.001) and after the PSM analysis (34.6% vs. 15.4%; p = 0.002). Multivariable analysis revealed sarcopenia to be associated with AKI before (p = 0.010) and after PSM (p = 0.016). Sarcopenia was also associated with overall mortality before (p = 0.048) and after PSM (p = 0.032). A Kaplan–Meier analysis revealed that overall mortality was elevated patients with sarcopenia before and after PSM than in those without (log-rank test, p < 0.001, p = 0.022). Conclusions: Sarcopenia was associated with increased postoperative AKI incidence and overall mortality among individuals who underwent infrarenal AAA operation.